By combining and extending the proven capabilities of Dragon Medical One (DMO) and DAX Copilot (DAX), Dragon Copilot promotes clinician well-being, increases...
Counterpart Health, MEDITECH, and Suki are using Vertex AI Search for healthcare to improve clinicians' access to information and gain...
Groundbreaking intelligence addresses a $1B industry problem, helping healthcare organizations streamline billing workflows and receive accurate reimbursement SAN FRANCISCO, March...
JUNO BEACH, Fla., March 3, 2025 /PRNewswire/ -- Juno Health, a leader in healthcare innovation and digital transformation, is partnering...
Leading the Way in Healthcare Innovation Across the Medication Journey SAN ANTONIO, March 3, 2025 /PRNewswire/ -- DrFirst, a leading...
One of Ohio's largest integrated health systems deploys the 1Clearsense Platform to create a longitudinal EHR, enabling comprehensive access to...
Clearlake to Acquire ModMed from Warburg Pincus BOCA RATON, Fla., March 3, 2025 /PRNewswire/ -- ModMed® (the "Company"), a pioneer in specialty-specific healthcare...
New functionality within Counterpart Assistant uses Google Cloud’s Vertex AI Search to give clinicians comprehensive insights across multiple sources of...
Top-line data for REFOCUS-ALZ, the second Phase 3 study of simufilam in Alzheimer’s disease, expected late first-quarter/early second-quarter 2025License agreement...
LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Two-year efficacy and safety data analyses from Phase III SUNSHINE and SUNRISE trials of continuous Cosentyx® (secukinumab) treatment in HS...
If approved, daratumumab will be the only anti-CD38 available for all patient types across newly diagnosed multiple myeloma, cementing daratumumab...
If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney...
Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product...
Cash and cash equivalents of $131.9M as of December 31, 2024 Cash runway extends through anticipated topline data readouts of...
ATLANTA, Feb. 27, 2025 /PRNewswire/ -- A new study published in the New England Journal of Medicine reveals that clinician-trained AI...
WATERLOO, ON, Feb. 27, 2025 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX) will showcase its industry-leading ability to deliver secure communications, streamlined...
Seamlessly integrated into CliniComp's advanced EHR Solution Suite, Intrinsic AI™ streamlines workflows, enhances efficiency, and reduces cognitive burden without requiring additional...
Two immersive future-focused days of programming in education and health, bringing together leading innovators, VCs, policymakers, researchers and entrepreneurs for...
From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support SOUTH...